Search results
Results From The WOW.Com Content Network
Microcrystalline Cellulose Market to Reach USD 1,794.1 Million by 2033, Driven by Growing Demand in Pharmaceuticals, Food & Beverages, and Industrial Applications | Future Market Insights, Inc. NEWARK, Del, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The global microcrystalline cellulose market is projected to experience substantial growth, with a ...
Demand for powdered cellulose in Japan is set to grow at a 9.7% CAGR through 2033, with regional sales rising from USD 10.31 million in 2023 to USD 26.14 million. Our analysis forecasts powdered cellulose sales in Korea to reach USD 9.10 million in 2023, with demand growing at an 11% CAGR to USD 25.84 million by 2033.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Pfizer (NYSE: PFE) became a stock market star in early pandemic days as it brought the first coronavirus vaccine to market. The company generated billions of dollars in revenue thanks to its ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
' Swedish Cellulose Stock Corporation SCA ') is a Swedish timber, pulp and paper manufacturer with headquarters in Sundsvall. [6] It has approximately 3,300 employees and a turnover of approximately SEK 20.8 billion (€1.8 billion). Its main products include many one-use paper products, containerboard, solid-wood products, pulp and forest ...
Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage biotech that may have that level of potential. The company harnesses artificial intelligence (AI) for drug discovery, promising to ...
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.